Eligibility Criteria

Inclusion and exclusion criteria
Descrição

Inclusion and exclusion criteria

Participant has a confirmed diagnosis of non-B-cell acute lymphoblastic leukemia (ALL)
Descrição

Participant has a confirmed diagnosis of non-B-cell acute lymphoblastic leukemia (ALL)

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0023492
UMLS CUI [1,3]
C0023449
Participant is less than or equal to 18 years of age
Descrição

Participant is less than or equal to 18 years of age

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0001779
Written, informed consent following NCI, IRB, FDA, and OPRR Guidelines
Descrição

Written, informed consent following NCI, IRB, FDA, and OPRR Guidelines

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0021430
Patient received high-dose methotrexate as part of protocol-directed therapy for ALL
Descrição

Patient received high-dose methotrexate as part of protocol-directed therapy for ALL

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0087111
UMLS CUI [1,3]
C0444956
UMLS CUI [1,4]
C0025677

Similar models

Eligibility Criteria

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Inclusion and exclusion criteria
Participant has a confirmed diagnosis of non-B-cell acute lymphoblastic leukemia (ALL)
Item
Participant has a confirmed diagnosis of non-B-cell acute lymphoblastic leukemia (ALL)
boolean
C1512693 (UMLS CUI [1,1])
C0023492 (UMLS CUI [1,2])
C0023449 (UMLS CUI [1,3])
Participant is less than or equal to 18 years of age
Item
Participant is less than or equal to 18 years of age
boolean
C1512693 (UMLS CUI [1,1])
C0001779 (UMLS CUI [1,2])
Written, informed consent following NCI, IRB, FDA, and OPRR Guidelines
Item
Written, informed consent following NCI, IRB, FDA, and OPRR Guidelines
boolean
C1512693 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
Patient received high-dose methotrexate as part of protocol-directed therapy for ALL
Item
Patient received high-dose methotrexate as part of protocol-directed therapy for ALL
boolean
C1512693 (UMLS CUI [1,1])
C0087111 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C0025677 (UMLS CUI [1,4])